Stopping renin–angiotensin–aldosterone system inhibitors in kidney disease

This review highlights outcomes following the discontinuation of RASi, which is generally associated with worse outcomes across the spectrum of CKD, hyperkalemia, and AKI.

Authors

Institutions

Publication Details

Journal
Current Opinion in Nephrology & Hypertension
Published
2026-03-13
DOI
https://doi.org/10.1097/mnh.0000000000001173
Primary Topic
Potassium and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stopping renin–angiotensin–aldosterone system inhibitors in kidney disease

Eva Glenn Lecea, Krystle Frazier, Elaine Ku
Current Opinion in Nephrology & Hypertension
Potassium and Related Disorders
article

Stopping renin–angiotensin–aldosterone system inhibitors in kidney disease

Eva Glenn Lecea, Krystle Frazier, Elaine Ku
article en

Abstract

This review highlights outcomes following the discontinuation of RASi, which is generally associated with worse outcomes across the spectrum of CKD, hyperkalemia, and AKI.

Current Opinion in Nephrology & HypertensionVol. 35(3)
University of California, San Francisco (US)
Good health and well-being
Openalex Percentile: Top 22%
Potassium and Related Disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.